These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28878924)

  • 21. Persistent supravenous erythematous eruption: a rare local complication of intravenous 5-fluorouracil therapy.
    Pujol RM; Rocamora V; Lopez-Pousa A; Taberner R; Alomar A
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):839-42. PubMed ID: 9810911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serpentine supravenous 5-fluorouracil (NSC-19893) hyperpigmentation.
    Hrushesky WJ
    Cancer Treat Rep; 1976 May; 60(5):639. PubMed ID: 991154
    [No Abstract]   [Full Text] [Related]  

  • 23. Persistent serpentine supravenous hyperpigmented eruption in leprosy.
    Kavak A; Karahacıoğlu FB; Gül İ; Taşmalı MK; Cimilli T; Baytekin F
    J Am Acad Dermatol; 2012 Aug; 67(2):e77-8. PubMed ID: 22794822
    [No Abstract]   [Full Text] [Related]  

  • 24. Serpentine supravenous hyperpigmentation following cisplatin and pemetrexed chemotherapy.
    Noori M; Hunter-Ellul L; Kelly B
    Cutis; 2017 Apr; 99(4):E20-E22. PubMed ID: 28492604
    [No Abstract]   [Full Text] [Related]  

  • 25. Serpentine Supravenous Hyperpigmentation.
    Maalouf NS; Morand M
    N Engl J Med; 2022 Dec; 387(25):e67. PubMed ID: 36546629
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy-induced persistent serpentine supra-venous hyperpigmented eruption and persistent supra-venous erythematous eruption: case report.
    Marongiu P; Lissia A; Cottoni F
    G Ital Dermatol Venereol; 2009 Feb; 144(1):97-100. PubMed ID: 19218916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serpentine supravenous hyperpigmentation secondary to superficial venous thrombosis in autoimmune hemolytic anemia.
    Avarbock AB; Gill KZ; Lauren CT; Chong DH; Silvers DN; Grossman ME
    Int J Dermatol; 2014 Feb; 53(2):e96-7. PubMed ID: 23330569
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pigmentary disorders induced by anticancer agents. part I: chemotherapy].
    Sibaud V; Fricain JC; Baran R; Robert C
    Ann Dermatol Venereol; 2013 Mar; 140(3):183-96. PubMed ID: 23466151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supravenous hyperpigmentation induced by vinorelbine.
    Cecchi R; Tuci F; Giomi A; Innocenti F
    Dermatology; 1994; 188(3):244. PubMed ID: 8186521
    [No Abstract]   [Full Text] [Related]  

  • 30. Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
    Chen GY; Lee JY; Chen WC
    Br J Dermatol; 2005 Jun; 152(6):1383-5. PubMed ID: 15949026
    [No Abstract]   [Full Text] [Related]  

  • 31. Supravenous discoloration of the skin due to docetaxel treatment.
    Schrijvers D; Van Den Brande J; Vermorken JB
    Br J Dermatol; 2000 May; 142(5):1069-70. PubMed ID: 10809894
    [No Abstract]   [Full Text] [Related]  

  • 32. Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma.
    Schulte-Huermann P; Zumdick M; Ruzicka T
    Dermatology; 1995; 191(1):65-7. PubMed ID: 8589490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous reaction associated with weekly docetaxel administration.
    Chew L; Chuen VS
    J Oncol Pharm Pract; 2009 Mar; 15(1):29-34. PubMed ID: 18753180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supravenous hyperpigmentation, transverse leuconychia and transverse melanonychia after chemotherapy for Hodgkin's disease.
    Lang K; Groeger M; Neumann NJ; Ruzicka T; Fritsch C
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):162-3. PubMed ID: 12046824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unusual pigmentary changes associated with 5-fluorouracil therapy.
    Hrushesky WJ
    Cutis; 1980 Aug; 26(2):181-82. PubMed ID: 7408538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent docetaxel-induced supravenous erythematous eruption.
    Fernandes Kde A; Felix PA
    An Bras Dermatol; 2015; 90(5):728-30. PubMed ID: 26560218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusual serpentine hyperpigmentation associated with 5-fluorouracil. Case report and review of cutaneous manifestations associated with systemic 5-fluorouracil.
    Vukelja SJ; Bonner MW; McCollough M; Cobb PW; Gaule DA; Fanucchi PJ; Keeling JH
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):905-8. PubMed ID: 1837033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-associated hyperpigmentation of the oral mucosa: report of four cases.
    Tosios KI; Kalogirou EM; Sklavounou A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Mar; 125(3):e54-e66. PubMed ID: 29287748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: Photodistributed reticulated hyperpigmentation related to diltiazem.
    Jaka A; López-Pestaña A; Tuneu A; Lobo C; López-Núñez M; Ormaechea N
    Dermatol Online J; 2011 Jul; 17(7):14. PubMed ID: 21810399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minocycline-induced hyperpigmentation in leprosy.
    Fleming CJ; Hunt MJ; Salisbury EL; McCarthy SW; Barnetson RS
    Br J Dermatol; 1996 Apr; 134(4):784-7. PubMed ID: 8733393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.